{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:23:17Z","timestamp":1791091397209,"version":"4.1.0"},"reference-count":60,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010611","type":"journal-article","created":{"date-parts":[[2013,6,24]],"date-time":"2013-06-24T17:59:50Z","timestamp":1372096790000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults"],"prefix":"10.1002","volume":"2016","author":[{"given":"Mattias","family":"Linde","sequence":"first","affiliation":[{"name":"Norwegian University of Science and Technology; Department of Neuroscience; Trondheim Norway"},{"name":"St. Olav\u2019s University Hospital; Norwegian Advisory Unit on Headaches; Trondheim Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim M","family":"Mulleners","sequence":"additional","affiliation":[{"name":"Canisius Wilhelmina Ziekenhuis; Department of Neurology; PO Box 9015 Nijmegen Netherlands 6500 GS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward P","family":"Chronicle","sequence":"additional","affiliation":[{"name":"University of Hawaii at Manoa; (Deceased) Department of Psychology; Manoa USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas C","family":"McCrory","sequence":"additional","affiliation":[{"name":"Duke University Medical Center; Department of Medicine; Durham NC USA 27710"},{"name":"Durham Veterans Affairs Medical Center; Center for Health Services Research in Primary Care; 508 Fulton St Durham NC USA 27705"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,6,24]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD010611-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/00207454.2011.626908","article-title":"A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis","volume":"122","author":"Afshari","year":"2012","journal-title":"International Journal of Neuroscience"},{"issue":"11","key":"10.1002\/14651858.CD010611-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/WNL.58.11.1652","article-title":"A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis","volume":"58","author":"Freitag","year":"2002","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD010611-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1468-2982.1992.1202081.x","article-title":"Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo","volume":"12","author":"Hering","year":"1992","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1002\/14651858.CD010611-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1212\/WNL.44.4.647","article-title":"Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study","volume":"44","author":"Jensen","year":"1994","journal-title":"Neurology"},{"issue":"9","key":"10.1002\/14651858.CD010611-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/archneur.1997.00550210071015","article-title":"A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura","volume":"54","author":"Kaniecki","year":"1997","journal-title":"Archives of Neurology"},{"issue":"8","key":"10.1002\/14651858.CD010611-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1046\/j.1526-4610.2001.01142.x","article-title":"Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open-label study","volume":"41","author":"Kinze","year":"2001","journal-title":"Headache"},{"issue":"2","key":"10.1002\/14651858.CD010611-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1468-2982.1997.1702103.x","article-title":"Divalproex sodium in migraine prophylaxis: a dose-controlled study","volume":"17","author":"Klapper","year":"1997","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1002\/14651858.CD010611-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/archneur.1995.00540270077022","article-title":"Migraine prophylaxis with divalproex","volume":"52","author":"Mathew","year":"1995","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD010611-BIB0009|cit9","first-page":"267","article-title":"Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open, clinical trial","volume":"12","author":"Mitsikostas","year":"1997","journal-title":"Functional Neurology"},{"issue":"4","key":"10.1002\/14651858.CD010611-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1526-4610.2006.00413.x","article-title":"Comparison of the effect of topiramate and sodium valproate in migraine prevention: a randomized blinded crossover study","volume":"46","author":"Shaygannejad","year":"2006","journal-title":"Headache"},{"issue":"10","key":"10.1002\/14651858.CD010611-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s001150050364","article-title":"Valproic acid in the prophylactic treatment of migraine","volume":"69","author":"Arnold","year":"1998","journal-title":"Nervenarzt"},{"issue":"6","key":"10.1002\/14651858.CD010611-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.wnf.0000192136.46145.44","article-title":"Efficacy of topiramate and valproate in chronic migraine","volume":"28","author":"Bartolini","year":"2005","journal-title":"Clinical Neuropharmacology"},{"issue":"5","key":"10.1002\/14651858.CD010611-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3923\/ijp.2010.670.675","article-title":"Assessment of the middle dose of topiramate in comparison with sodium valproate for migraine prophylaxis: a randomized double-blind study","volume":"6","author":"Bavrasad","year":"2010","journal-title":"International Journal of Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD010611-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1526-4610.2007.00949.x","article-title":"Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine","volume":"48","author":"Blumenfeld","year":"2008","journal-title":"Headache"},{"key":"10.1002\/14651858.CD010611-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1046\/j.1526-4610.2001.01154-2.x","article-title":"Antiepileptic drugs: how they work in headache","volume":"41 Suppl 1","author":"Cutrer","year":"2001","journal-title":"Headache"},{"issue":"6","key":"10.1002\/14651858.CD010611-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1034\/j.1600-0404.2000.102006354.x","article-title":"Valproic acid in prophylaxis of refractory migraine","volume":"102","author":"Erdemoglu","year":"2000","journal-title":"Acta Neurologica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD010611-BIB0017|cit17","first-page":"32","article-title":"Low dose of sodium divalproate for the treatment of migraine","volume":"5","author":"Fragoso","year":"2003","journal-title":"MedGenMed [electronic resource]: Medscape General Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010611-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1358\/mf.1998.20.4.485692","article-title":"Prophylactic sodium valproate therapy in patients with drug-resistant migraine","volume":"20","author":"Ghose","year":"1998","journal-title":"Methods & Findings in Experimental & Clinical Pharmacology"},{"issue":"8","key":"10.1002\/14651858.CD010611-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1526-4610.2005.05184.x","article-title":"Effect of divalproex on metabolic parameters is dose related in migraine prophylaxis","volume":"45","author":"Green","year":"2005","journal-title":"Headache"},{"issue":"15","key":"10.1002\/14651858.CD010611-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.3923\/pjbs.2009.1098.1101","article-title":"Comparison of treatment effect of sodium valproate, propranolol and tricyclic antidepressants in migraine","volume":"12","author":"Keyvan","year":"2009","journal-title":"Pakistan Journal of Biological Sciences"},{"issue":"4","key":"10.1002\/14651858.CD010611-BIB0021|cit21","first-page":"50","article-title":"An open label cross-over comparison of divalproex sodium and propanolol HCl in the prevention of migraine headaches","volume":"5","author":"Klapper","year":"1994","journal-title":"Headache Quarterly"},{"issue":"4","key":"10.1002\/14651858.CD010611-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1526-4610.2011.01868.x","article-title":"Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective \"real-world\" study","volume":"51","author":"Krymchantowski","year":"2011","journal-title":"Headache"},{"issue":"2","key":"10.1002\/14651858.CD010611-BIB0023|cit23","first-page":"126","article-title":"Sodium valproate in severe migraine and tension-type headache: an open study of long-term efficacy and correlation with blood levels","volume":"96","author":"Lenaerts","year":"1996","journal-title":"Acta Neurologica Belgica"},{"issue":"10","key":"10.1002\/14651858.CD010611-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1468-1331.2007.01744.x","article-title":"Subcutaneous histamine versus sodium valproate in migraine prophylaxis: a randomized, controlled, double-blind study","volume":"14","author":"Millan-Guerrero","year":"2007","journal-title":"European Journal of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD010611-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1468-2982.1994.014003241.x","article-title":"A differential response to treatment with divalproex sodium in patients with intractable headache","volume":"14","author":"Rothrock","year":"1994","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1002\/14651858.CD010611-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1468-2982.1997.1702081.x","article-title":"Clinical studies of valproate for migraine prophylaxis","volume":"17","author":"Rothrock","year":"1997","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1002\/14651858.CD010611-BIB0027|cit27","first-page":"264","article-title":"The safety and efficacy of divalproex sodium in the prophylaxis of migraine headache: a multicenter, double-blind, placebo-controlled trial","volume":"33","author":"Silberstein","year":"1993","journal-title":"Headache"},{"issue":"4","key":"10.1002\/14651858.CD010611-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0404.1988.tb03667.x","article-title":"Valproate: a new drug in migraine prophylaxis","volume":"78","author":"S\u00f8rensen","year":"1988","journal-title":"Acta Neurologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD010611-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10194-008-0013-2","article-title":"Cinnarizine in refractory migraine prophylaxis: Efficacy and tolerability. A comparison with sodium valproate","volume":"9","author":"Togha","year":"2008","journal-title":"Journal of Headache & Pain"},{"issue":"9","key":"10.1002\/14651858.CD010611-BIB0030|cit30","first-page":"717","article-title":"Classification of headache","volume":"179","author":"Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness","year":"1962","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD010611-BIB0031|cit31","unstructured":"Alderson P Green S Higgins JPT Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]; Appendix 5b In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd"},{"issue":"1","key":"10.1002\/14651858.CD010611-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/oxfordjournals.qjmed.a030141","article-title":"Economic and social impact of migraine","volume":"89","author":"Clarke","year":"1996","journal-title":"QJM"},{"issue":"2","key":"10.1002\/14651858.CD010611-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1468-2982.1997.1702093.x","article-title":"Possible mechanisms of valproate in migraine prophylaxis","volume":"17","author":"Cutrer","year":"1997","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1002\/14651858.CD010611-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2174\/156802612800229215","article-title":"Recent progress in anticonvulsant drug research: strategies for anticonvulsant drug development and applications of antiepileptic drugs for non-epileptic central nervous system disorders","volume":"12","author":"Dalkara","year":"2012","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"2","key":"10.1002\/14651858.CD010611-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S0317167100047697","article-title":"Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey","volume":"20","author":"Edmeads","year":"1993","journal-title":"Canadian Journal of Neurological Sciences"},{"issue":"9741","key":"10.1002\/14651858.CD010611-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(10)60323-6","article-title":"New drugs in migraine treatment and prophylaxis: telcagepant and topiramate","volume":"376","author":"Edvinsson","year":"2010","journal-title":"Lancet"},{"issue":"9","key":"10.1002\/14651858.CD010611-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1468-1331.2009.02748.x","article-title":"EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force","volume":"16","author":"Evers","year":"2009","journal-title":"European Journal of Neurology"},{"issue":"9859","key":"10.1002\/14651858.CD010611-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2013","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010611-BIB0039|cit39","first-page":"1","article-title":"The International Classification of Headache Disorders: 2nd edition","volume":"24 Suppl 1","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD010611-BIB0040|cit40","first-page":"1","article-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain","volume":"8 Suppl 7","author":"Headache Classification Committee of the International Headache Society","year":"1988","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1002\/14651858.CD010611-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"2","key":"10.1002\/14651858.CD010611-BIB0042|cit42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003225.pub2","article-title":"Propranolol for migraine prophylaxis","author":"Linde","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD010611-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1468-1331.2011.03612.x","article-title":"The cost of headache disorders in Europe: the Eurolight project","volume":"19","author":"Linde","year":"2012","journal-title":"European Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD010611-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010610","article-title":"Topiramate for the prophylaxis of episodic migraine in adults","author":"Linde","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010611-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010611","article-title":"Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults","author":"Linde","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010611-BIB0046|cit46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010609","article-title":"Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults","author":"Linde","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010611-BIB0047|cit47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010608","article-title":"Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults","author":"Linde","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010611-BIB0048|cit48","volume-title":"An Evidence-based Resource for Pain Relief","author":"McQuay","year":"1998"},{"issue":"8","key":"10.1002\/14651858.CD010611-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1468-1331.2012.03681.x","article-title":"Self-medication of regular headache: a community pharmacy-based survey","volume":"19","author":"Mehuys","year":"2012","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD010611-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1528-1157.44.s4.2.x","article-title":"Reproductive and metabolic disorders in women with epilepsy","volume":"44 Suppl 4","author":"Morrell","year":"2003","journal-title":"Epilepsia"},{"issue":"6","key":"10.1002\/14651858.CD010611-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1468-2982.2006.01172.x","article-title":"New appendix criteria open for a broader concept of chronic migraine","volume":"26","author":"Olesen","year":"2006","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD010611-BIB0052|cit52","first-page":"331","article-title":"Antiepileptic drugs","volume-title":"Basic and Clinical Pharmacology","author":"Porter","year":"1992"},{"issue":"10","key":"10.1002\/14651858.CD010611-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"907","DOI":"10.33588\/rn.3610.2002450","article-title":"Effectiveness of flunarizine in the prophylaxis of migraine: a meta-analytical review of the literature","volume":"36","author":"Reveiz-Herault","year":"2003","journal-title":"Revista de Neurologia"},{"issue":"7","key":"10.1002\/14651858.CD010611-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1212\/01.wnl.0000297551.27191.70","article-title":"Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study","volume":"70","author":"Silberstein","year":"2008","journal-title":"Neurology"},{"issue":"17","key":"10.1002\/14651858.CD010611-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","article-title":"Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society","volume":"78","author":"Silberstein","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD010611-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0333102411417901","article-title":"Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators","volume":"32","author":"Tfelt-Hansen","year":"2012","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1002\/14651858.CD010611-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002761","article-title":"Drugs for preventing migraine headaches in children","author":"Victor","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD010611-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001133.pub3","article-title":"Anticonvulsant drugs for acute and chronic pain","author":"Wiffen","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD010611-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003226.pub2","article-title":"Anticonvulsant drugs for migraine prophylaxis","author":"Chronicle","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010611-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1468-2982.2008.01571.x","article-title":"Anticonvulsants in migraine prophylaxis: a Cochrane review","volume":"28","author":"Mulleners","year":"2008","journal-title":"Cephalalgia"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD010611\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T08:36:31Z","timestamp":1690446991000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010611"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,24]]},"references-count":60,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010611","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,24]]}}}